Wednesday, July 8, 2026
🇺🇸 FDA

pharma · HNSCC · Squamous Cell Carcinoma of the Skin · PHIO

Phio Pharmaceuticals

Phio Pharmaceuticals patent portfolio — 39 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
King of Prussia, USA HQ
2012 Founded
15 Employees
Public company Type
PHIO · NYSE Ticker
Company details
Status
Public
HQ
King of Prussia, USA
Founded
2012
Employees
15
Programs
2
Drugs
0
Patents
39
Official website ↗ All projects Patents News & analysis
Intelligence · Patents

Phio Pharmaceuticals patents

39 pharmaceutical patents indexed for Phio Pharmaceuticals. 1 expire within 24 months.

Phio Pharmaceuticals has 39 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

39 patents

Patent portfolio

  1. US 11926828

    Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11639359

    Bryoid compositions, methods of making and use thereof

    Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11584933

    RNA interference in ocular indications

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11396654

    Neutral nanotransporters

    Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11279934

    Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11254940

    Inhibition of MAP4K4 through RNAi

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11234932

    Combination HIV therapeutic

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11118178

    Reduced size self-delivering RNAI compounds

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11021707

    Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11001845

    Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10954248

    Bryoid compositions, methods of making and use thereof

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10934550

    Immunotherapy of cancer

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10913948

    RNA interference in dermal and fibrotic indications

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10900039

    Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10876119

    Reduced size self-delivering RNAI compounds

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10815485

    RNA interference in skin indications

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10808247

    Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10774330

    Reduced size self-delivering RNAI compounds

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10662430

    RNA interference in ocular indications

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10633654

    Modified RNAi polynucleotides and uses thereof

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10493030

    Combination HIV therapeutic

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10485766

    Drug delivery system and method for the treatment of neuro-degenerative disease

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10300027

    Effective sensitizing dose of a gelled immunomodulating topical composition

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10258635

    Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10240149

    Reduced size self-delivering RNAi compounds

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10184124

    RNA interference in ocular indications

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9994585

    Transplantation therapies

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9981238

    Apparatus and methods for making nanosomes loaded with nucleic acid

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9034347

    Drug delivery system and method for the treatment of neuro-degenerative disease

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8703727

    Nanotechnology formulation of poorly soluble compounds

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8637074

    Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8629177

    Nanoencapsulated delta-9-tetrahydrocannabinol

    Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8440614

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8435575

    Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8350126

    Green garlic and methods of production

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8070467

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7937889

    Green garlic and methods of production

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7147806

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7037534

    Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds

    Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Phio Pharmaceuticals have?

39 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Phio Pharmaceuticals patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.